Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$760M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
| 3 |
NVIDIA
NVDA
|
+$287M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$268M |
| 5 |
XYZ
Block Inc
XYZ
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$475M |
| 2 |
Pfizer
PFE
|
+$356M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 4 |
Apple
AAPL
|
+$325M |
| 5 |
Microsoft
MSFT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 12.18% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Encore Capital Group
ECPG
$2.15B
| $4.08M | ﹤0.01% |
173,401
-609,063
| -78% | -$16.4M |
|
2202
NWPX Infrastructure Inc
NWPX
$1.11B
| $4.07M | ﹤0.01% |
174,559
-36,779
| -17% | -$783K |
|
2203
The Bancorp
TBBK
$2.82B
| $4.06M | ﹤0.01% |
510,430
-12,600
| -2% | -$118K |
|
|
BGG
2204
DELISTED
Briggs & Stratton Corp.
BGG
| $4.06M | ﹤0.01% |
310,655
-7,838
| -2% | -$121K |
|
|
APTS
2205
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $4.06M | ﹤0.01% |
288,610
+35,495
| +14% | +$555K |
|
|
ASRT
2206
DELISTED
Assertio
ASRT
| $4.05M | ﹤0.01% |
18,717
+4,423
| +31% | +$1.33M |
|
2207
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
| $4.05M | ﹤0.01% |
392,388
+76,972
| +24% | +$879K |
|
2208
Henry Schein
HSIC
$10B
| $4.05M | ﹤0.01% |
65,688
+1,094
| +2% | +$72K |
|
2209
Vornado Realty Trust
VNO
$7.41B
| $4.04M | ﹤0.01% |
65,158
-14,936
| -19% | -$1.02M |
|
2210
Invesco S&P SmallCap Health Care ETF
PSCH
$171M
| $4.04M | ﹤0.01% |
112,611
-163,230
| -59% | -$6.68M |
|
|
BDSI
2211
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $4.03M | ﹤0.01% |
1,090,340
-45,856
| -4% | -$161K |
|
|
CNSL
2212
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $4.03M | ﹤0.01% |
407,592
-26,856
| -6% | -$330K |
|
|
SOR
2213
Source Capital
SOR
$384M
| $4.01M | ﹤0.01% |
123,090
+8,699
| +8% | +$315K |
|
2214
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
| $4M | ﹤0.01% |
56,016
+30,137
| +116% | +$2.3M |
|
2215
Triumph Financial Inc
TFIN
$1.87B
| $4M | ﹤0.01% |
134,530
-88,665
| -40% | -$3.13M |
|
2216
Pacira BioSciences
PCRX
$924M
| $4M | ﹤0.01% |
92,857
+44,181
| +91% | +$2.06M |
|
2217
W&T Offshore
WTI
$546M
| $3.99M | ﹤0.01% |
969,301
-15,463
| -2% | -$98.8K |
|
2218
Conduent
CNDT
$252M
| $3.98M | ﹤0.01% |
374,445
+167,234
| +81% | +$2.61M |
|
2219
Quad
QUAD
$506M
| $3.98M | ﹤0.01% |
322,812
+25,404
| +9% | +$410K |
|
2220
WisdomTree US AI Enhanced Value Fund
AIVL
$438M
| $3.98M | ﹤0.01% |
51,667
+3,455
| +7% | +$292K |
|
2221
Mercury Insurance
MCY
$5.81B
| $3.97M | ﹤0.01% |
76,857
-2,370
| -3% | -$129K |
|
2222
Travere Therapeutics
TVTX
$5.79B
| $3.96M | ﹤0.01% |
175,179
+71,371
| +69% | +$1.78M |
|
|
GTS
2223
DELISTED
Triple-S Management Corporation
GTS
| $3.96M | ﹤0.01% |
239,529
+16,765
| +8% | +$290K |
|
|
ESV
2224
DELISTED
Ensco Rowan plc
ESV
| $3.96M | ﹤0.01% |
277,866
-27,753
| -9% | -$715K |
|
|
NE
2225
DELISTED
Noble Corporation
NE
| $3.96M | ﹤0.01% |
1,509,296
+9,305
| +0.6% | +$44.2K |
|
Similar funds
Ameriprise's Q4 2018 Portfolio in Review
As of Q4 2018, Ameriprise held 3,899 positions worth $200B, down 30% from $286B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q4 2018 filing shows 170 new, 1,630 increased, 1,715 reduced and 248 closed positions. Its largest new stake was Linde: 460,065 shares worth $71.8M. The largest sale was Express Scripts Holding Company, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2018 buy was Linde: 460,065 shares worth $71.8M.
- Ameriprise added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $760M increase.
- Ameriprise's biggest Q4 2018 reduction was Pfizer, cutting an estimated $356M.
- Ameriprise fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $475M.
- Ameriprise's ten largest holdings make up 14% of its $200B portfolio in Q4 2018.
- Ameriprise opened 170 new positions and closed 248 in Q4 2018.
- Ameriprise's portfolio value fell 30% quarter-over-quarter to $200B.
Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.